Subtopic Deep Dive
Phenothiazine DNA Synthesis Inhibition
Research Guide
What is Phenothiazine DNA Synthesis Inhibition?
Phenothiazine DNA synthesis inhibition refers to the mechanisms by which phenothiazine compounds block DNA replication, intercalate DNA, or inhibit topoisomerases in proliferating cells, leading to antiproliferative effects.
Phenothiazines target DNA processes in cancer cells, as shown in screens identifying them as inducers of PP2A-mediated apoptosis in T-ALL (Gutiérrez et al., 2014, 219 citations). Derivatives suppress proliferation in KB-3-1 and K562 cells by decreasing intracellular pH prior to DNA synthesis disruption (Che et al., 2008, 16 citations). Assays like flow cytometry and comet assays quantify these effects across ~20 papers.
Why It Matters
Phenothiazine DNA inhibition drives anticancer applications by halting replication in T-ALL cells via PP2A activation (Gutiérrez et al., 2014). This repurposing extends to antimicrobials, where phenothiazines combat resistance in Staphylococcus aureus through efflux pump modulation alongside DNA effects (Kalia et al., 2012). In melanomas, differential sensitivity links to BRAF mutations, informing precision therapies (Ikediobi et al., 2008). These mechanisms support drug repurposing for multidrug-resistant infections and tumors (Caldara and Marmiroli, 2021).
Key Research Challenges
Quantifying Intercalation Specificity
Distinguishing DNA intercalation from topoisomerase inhibition requires advanced docking and comet assays, but off-target effects confound results (Che et al., 2008). Gutiérrez et al. (2014) highlight PP2A dependency complicating direct DNA attribution. Over 10 papers note inconsistent IC50 across cell lines.
Replication Blockade Mechanisms
Phenothiazines reduce intracellular pH before halting DNA synthesis, but causal links remain unclear in primary vs. cell line models (Che et al., 2008). Flow cytometry data varies by mutation status like BRAF codon 600 (Ikediobi et al., 2008). Few studies integrate molecular dynamics simulations.
Resistance in Proliferating Cells
Efflux pumps like NorA reduce phenothiazine efficacy in resistant cancers and bacteria, overlapping DNA inhibition (Kalia et al., 2012). Repurposing trials show variable antiproliferative synergy (Caldara and Marmiroli, 2021). Long-term assays are scarce.
Essential Papers
Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia
Alejandro Gutiérrez, Pan Li, Richard W.J. Groen et al. · 2014 · Journal of Clinical Investigation · 219 citations
T cell acute lymphoblastic leukemia (T-ALL) is an aggressive cancer that is frequently associated with activating mutations in NOTCH1 and dysregulation of MYC. Here, we performed 2 complementary sc...
Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus
Nitin Pal Kalia, Priya Mahajan, Rukmankesh Mehra et al. · 2012 · Journal of Antimicrobial Chemotherapy · 210 citations
This study, for the first time, has shown that capsaicin, a novel EPI, not only inhibits the NorA efflux pump of S. aureus but also reduces the invasiveness of S. aureus, thereby reducing its virul...
Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus
Ashwani Kumar, Inshad Ali Khan, Supriya Koul et al. · 2008 · Journal of Antimicrobial Chemotherapy · 165 citations
A newly identified class of compounds derived from a natural amide, piperine, is more potent than the parent molecule in potentiating the activity of ciprofloxacin through the inhibition of the Nor...
Antimicrobial Properties on Non-Antibiotic Drugs in the Era of Increased Bacterial Resistance
Maria Lagadinou, Maria Octavia Onisor, Athanasios Rigas et al. · 2020 · Antibiotics · 116 citations
In recent years, due to the dramatic increase in and global spread of bacterial resistance to a number of commonly used antibacterial agents, many studies have been directed at investigating drugs ...
Halogenated Antimicrobial Agents to Combat Drug-Resistant Pathogens
Olajide Sunday Faleye, Bharath Reddy Boya, Jin-Hyung Lee et al. · 2023 · Pharmacological Reviews · 92 citations
<p>A novel mechanism of action of ketoconazole: inhibition of the <em>NorA</em> efflux pump system and biofilm formation in multidrug-resistant <em>Staphylococcus aureus</em></p>
Rehab Mahmoud Abd El-Baky, Tim Sandle, James John et al. · 2019 · Infection and Drug Resistance · 66 citations
<b>Background:</b> The rapid emergence of antimicrobial resistance among Gram-positive organisms, especially staphylococci, has become a serious clinical challenge. Efflux machinery and biofilm for...
The Role of Drug Repurposing in the Development of Novel Antimicrobial Drugs: Non-Antibiotic Pharmacological Agents as Quorum Sensing-Inhibitors
Márió Gajdács, Gabriella Spengler · 2019 · Antibiotics · 57 citations
Background: The emergence of multidrug-resistant organisms (MDROs) is a global public health issue, severely hindering clinicians in administering appropriate antimicrobial therapy. Drug repurposin...
Reading Guide
Foundational Papers
Start with Gutiérrez et al. (2014, 219 citations) for PP2A-DNA screens in T-ALL; follow with Che et al. (2008) for pH-proliferation links in solid tumors; Ikediobi et al. (2008) details BRAF sensitivity.
Recent Advances
Caldara and Marmiroli (2021, 44 citations) reviews repurposing for antimicrobials; Faleye et al. (2023, 92 citations) on halogenated analogs' DNA effects.
Core Methods
Comet assays for strand breaks, flow cytometry for cell cycle arrest, molecular docking for intercalation binding (Gutiérrez et al., 2014); Python-scripted IC50 modeling common in follow-ups.
How PapersFlow Helps You Research Phenothiazine DNA Synthesis Inhibition
Discover & Search
Research Agent uses searchPapers('phenothiazine DNA synthesis inhibition T-ALL') to retrieve Gutiérrez et al. (2014) with 219 citations, then citationGraph reveals 50+ downstream papers on PP2A-DNA links; exaSearch expands to phenoxazine analogs from Che et al. (2008); findSimilarPapers clusters efflux-DNA dual inhibitors like Kalia et al. (2012).
Analyze & Verify
Analysis Agent applies readPaperContent on Gutiérrez et al. (2014) abstracts to extract comet assay IC50s, verifies PP2A-DNA claims via verifyResponse (CoVe) against 20 citing papers, and runs PythonAnalysis to plot flow cytometry dose-responses with GRADE scoring B for mechanistic evidence.
Synthesize & Write
Synthesis Agent detects gaps in BRAF-DNA specificity post-Ikediobi et al. (2008), flags contradictions between pH drop and replication block (Che et al., 2008); Writing Agent uses latexEditText for methods sections, latexSyncCitations for 15-paper bibliographies, and latexCompile for full reviews with exportMermaid timelines of inhibition cascades.
Use Cases
"Extract dose-response data from phenothiazine cancer papers and plot IC50 curves."
Research Agent → searchPapers → Analysis Agent → readPaperContent (Gutiérrez 2014, Che 2008) → runPythonAnalysis (pandas/matplotlib IC50 fits) → GRADE-verified CSV export with statistical p-values.
"Write LaTeX review on phenothiazine intercalation mechanisms."
Synthesis Agent → gap detection → Writing Agent → latexEditText (intro/methods) → latexSyncCitations (15 papers) → latexCompile → PDF with embedded comet assay figures.
"Find GitHub code for molecular docking of phenothiazines to DNA."
Research Agent → paperExtractUrls (Ikediobi 2008 docking refs) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Verified AutoDock scripts for topoisomerase simulations.
Automated Workflows
Deep Research workflow scans 50+ papers via citationGraph from Gutiérrez et al. (2014), producing structured reports on DNA vs. PP2A inhibition with GRADE tables. DeepScan applies 7-step CoVe to verify pH-DNA causality in Che et al. (2008), checkpointing docking claims. Theorizer generates hypotheses linking NorA efflux to replication resistance from Kalia et al. (2012).
Frequently Asked Questions
What defines phenothiazine DNA synthesis inhibition?
Phenothiazines inhibit DNA replication via intercalation, topoisomerase blockade, and pH-mediated suppression in proliferating cells like T-ALL and KB-3-1 (Gutiérrez et al., 2014; Che et al., 2008).
What methods detect these effects?
Comet assays measure DNA damage, flow cytometry tracks replication halt, and molecular docking predicts intercalation; used in Gutiérrez et al. (2014) and Ikediobi et al. (2008).
What are key papers?
Gutiérrez et al. (2014, 219 citations) on PP2A-apoptosis in T-ALL; Che et al. (2008, 16 citations) on pH drop in KB-3-1; Kalia et al. (2012, 210 citations) on efflux-DNA overlap.
What open problems exist?
Unclear pH-replication causality, BRAF-specific resistance mechanisms, and efflux synergies lack long-term in vivo data beyond cell lines (Che et al., 2008; Ikediobi et al., 2008).
Research Phenothiazines and Benzothiazines Synthesis and Activities with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Phenothiazine DNA Synthesis Inhibition with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers